
MeAgain is the best compounded tirzepatide tracker because it logs custom vial doses, keeps shot day organized, and makes the weekly routine easier to follow. Compounded tirzepatide usually comes in a multi-dose vial, so most people need more than a simple reminder. MeAgain lets you record the exact mg you drew, the day and time, and the injection site on a tappable body diagram, then keeps a 90-day rotation history so you are not guessing next week. It also tracks 20 common GLP-1 symptoms on a 0-to-10 slider, shows your estimated medication level across the week, and pairs that with a weight trend and daily protein, water, fiber, and steps. MeAgain is the all-in-one GLP-1 tracking app trusted by 286,000 users, rated 4.8 stars across over 16,000 App Store ratings, and available for $9.99/month. If you want it, an optional in-app intake can connect eligible subscribers to licensed clinicians and US-based 503A and 503B pharmacies for compounded tirzepatide at $199/month flat.

This is the first job a compounded tirzepatide tracker has to get right. A single-dose pen only asks you to remember the preset step. A multi-dose vial asks you to remember what you drew, when you took it, and whether the amount changed from last week. MeAgain lets you log the exact mg with a tap-friendly input, stores the day and time, and keeps a running history so you can see every weekly change in one place. If your licensed clinician adjusts your plan, the next entry reflects it immediately. That update also feeds the medication graph, so the weekly rise-and-fall view stays accurate. Instead of trying to remember whether you took 5 mg or 6.25 mg last Tuesday, you have a clean log that matches the routine you actually follow.

MeAgain turns shot day into a repeatable routine instead of a guessing game. When you log a dose, you can tap the body diagram to mark stomach, thigh, or upper arm, with smaller zones that help you avoid using the same place over and over. The app keeps a 90-day history, so next week you can see what is rested instead of trying to remember where you injected last time. That matters when you are taking a weekly shot for months at a time. The same flow saves the date, time, and dose, then ties any side effects to that specific entry. A streak counter shows consecutive on-time weeks, and missed-shot detection makes gaps obvious before they turn into a pattern. The result is a calmer shot day and a cleaner record.

The side effect tracker is where the weekly routine starts making sense. MeAgain covers 20 common GLP-1 symptoms, plus custom entries, and lets you score each one on a 0-to-10 slider with a timestamp. That makes it easy to see whether nausea settled after two days, whether constipation shows up after every dose change, or whether fatigue is building across the week. Because each symptom entry sits next to your shot log, you can connect how you felt to the exact dose and day instead of relying on memory. Over a few weeks, the log becomes a clear timeline you can review before your next shot or bring to your licensed clinician if you are deciding whether to stay put, slow down, or ask questions. It is less guessing and more pattern recognition.

Compounded tirzepatide is easier to stay consistent with when the weekly shot and the daily routine live in the same app. MeAgain pairs a medication graph, which shows your estimated level across the seven days between shots, with a weight trend that helps you see progress without overreacting to day-to-day noise. The Capybara home screen widget keeps protein, water, fiber, and steps visible even when you do not open the app, and five food logging methods - photo scan, barcode, voice, text search, and quick-add - make it faster to track on low-appetite days. Together, those tools answer the questions most people have between injections: where am I in the week, how am I feeling, am I eating enough, and is my routine still working? That is what makes the app useful every day, not just on shot day.
Compounded tirzepatide is tirzepatide prepared by a state-licensed compounding pharmacy for an individual prescription. It is usually dispensed in a multi-dose vial, which means you draw your weekly amount yourself instead of using a single-dose pen. In the United States, compounding happens through two main pharmacy categories: 503A pharmacies, which fill prescriptions one at a time on a clinician's order, and 503B outsourcing facilities, which prepare larger batches and register with the FDA. Compounded tirzepatide is not an FDA-approved finished drug product, so the label, beyond-use date, storage instructions, and dose directions from your pharmacy matter. The tracker side is different too: you may need to log a custom mg amount, remember where you injected last week, and watch how symptoms change across the days after each shot. In the SURMOUNT-1 trial, adults receiving tirzepatide reached 20.9% average weight loss at 72 weeks in the highest-dose group (n=2,539), which helps explain why people often stay on the routine for months, not just weeks.
| Compounded Tirzepatide | FDA-Approved Tirzepatide Pen | |
|---|---|---|
| Format | Multi-dose vial and syringe | Single-dose pen |
| Dose control | Custom mg set by prescription | Preset weekly steps |
| Prescription path | Licensed clinician and compounding pharmacy | Licensed clinician and standard pharmacy |
| FDA status | Not FDA-approved as a finished drug product | FDA-approved finished drug product |
| MeAgain dose logging | Exact mg entry for each shot | Dose-step selection |
| MeAgain tracking features | Full support | Full support |
If compounded tirzepatide is part of your routine, MeAgain gives you one place to keep the routine straight: custom mg logging, injection-site rotation, 20-symptom tracking, estimated medication levels, weight trends, and daily protein, water, fiber, and steps. MeAgain is trusted by 286,000 users and rated 4.8 stars across over 16,000 App Store ratings. Eligible subscribers who want medication support can open the optional intake inside the same app.
This content is for informational purposes only and does not constitute medical advice. Compounded tirzepatide is not an FDA-approved finished drug product. Compounded prescriptions are written by a licensed clinician based on an individual medical intake and may not be appropriate for everyone. Tirzepatide carries an FDA warning about thyroid C-cell tumors observed in rodent studies. Always discuss your medical history and any compounded prescription with your licensed clinician. MeAgain is a tracking app; the in-app intake connects eligible subscribers to licensed clinicians and US-based compounding pharmacies, but MeAgain does not practice medicine or prepare medication.
Sources
Weekly shots are only part of the routine. The harder part is remembering food, hydration, weight, and dose details week after week without keeping notes in three different places. One App Store reviewer, Jazzyboo125, put it simply: “Love that I can track my protein, fiber and water . I also like that I’m able to keep up with my GLP1 dosage and weight loss”. That is exactly what this page promises. MeAgain keeps the custom dose log, the weight trend, and the daily habits in one place, so compounded tirzepatide feels like one routine instead of a pile of separate chores.
MeAgain is the GLP-1 app trusted by 286,000 users and rated 4.8 stars across over 16,000 App Store ratings because it handles the routine around the shot, not just the shot itself. You get custom mg logging for a vial, injection-site rotation, a weekly medication graph, a weight trend, five ways to log food, and the Capybara widget for protein, water, fiber, and steps. We make money from our $9.99/month app subscription. That's it. Eligible subscribers who want an optional self-pay path can open the in-app intake for compounded tirzepatide at $199/month flat, but the tracker also works if you already get your prescription elsewhere.

“Love that I can track my protein, fiber and water. I also like that I'm able to keep up with my GLP1 dosage and weight loss.”
“Love this app! Keeps me on task all day, every day. I hit my protein and fiber and this is the best I have felt in years!!!”
“This app has been a game changer for me! I never knew I could take a picture of my food and you guys would know exactly what it was. Thank you so much for making my life easier and forcing me to drink more water.”
“I just started using this app and it is crazy good really enjoying it how it finds by barcodes or package covers or scan a plate of food really cool.”
“Loving how easy it is to use this app for either just simple meds and weight tracking all the way to food planning if I want. And I get real time data on where I am towards my goal.”
Compounded tirzepatide is tirzepatide prepared by a state-licensed compounding pharmacy for an individual prescription, rather than sold as an FDA-approved finished drug product. It is commonly dispensed in a multi-dose vial, so you draw your weekly amount yourself. In the United States, compounding happens through 503A pharmacies, which fill prescriptions one at a time on a clinician's order, and 503B outsourcing facilities, which prepare larger batches and register with the FDA. Because compounded tirzepatide is not an FDA-approved finished drug product, the label, storage directions, beyond-use date, and dosing instructions from your pharmacy matter. That is also why tracking matters: many people need a clean record of the exact mg they drew, when they took it, and how they felt afterward. MeAgain gives you that log in one place, alongside injection sites, side effects, and weight.

Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.